Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorder
BREX augmentation modified MT-mRNA expressions in both in vitro and in vivo experiments. This may be a key finding in improving our understanding of MDD pathogenesis and clinical practice.
Authors
- Yuta Yoshino (ORCID: https://orcid.org/0000-0002-0687-0301)
- Kohei Kondo
- Jun‐ichi Iga (ORCID: https://orcid.org/0000-0003-4409-3096)
- Hiroshi Kumon (ORCID: https://orcid.org/0000-0002-6358-8169)
- Shuichi Ueno (ORCID: https://orcid.org/0000-0002-2611-962X)
- Hiroaki Mori (ORCID: https://orcid.org/0009-0002-1785-0944)
- Mitsutoshi Okano
Institutions
- Ehime University (JP)
Publication Details
- Journal
- Journal of Psychopharmacology
- Published
- 2025-05-06
- DOI
- https://doi.org/10.1177/02698811251337365
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Society for the Promotion of Science